Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors

The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas. To characterize the protein tyrosine kinases that are...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgical oncology Vol. 1; no. 1; pp. 18 - 27
Main Authors: Weiner, T M, Liu, E T, Craven, R J, Cance, W G
Format: Journal Article
Language:English
Published: United States 01-01-1994
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas. To characterize the protein tyrosine kinases that are expressed in human sarcomas, we used a polymerase chain reaction (PCR)-based method to construct kinase-specific cDNA libraries from low-grade and high-grade primary tumors. Thereafter, individual tyrosine kinase gene expression was assessed in a panel of sarcoma cell lines and primary tumors using Northern blotting and PCR. We identified 19 species of tyrosine kinase genes, including many growth factor receptors, the human homolog of the focal adhesion kinase (FAK) gene, and a novel trk-related kinase designated HGK2. Messenger RNA expression analyses showed relative overexpression of the two forms of the platelet-derived growth factor receptors (PDGFRs) with expression of the alpha form restricted to a subgroup of high-grad and metastatic sarcomas. We were unable to demonstrate coexpression of the PDGF isoforms in primary tumors that overexpressed the receptors, suggesting that a PDGF/PDGFR autocrine pathway may not be a central mechanism in the malignant transformation of sarcomas in vivo. FAK expression was observed in a variety of sarcomas, with increased levels in several high-grade and metastatic leiomyosarcomas. When grouped together by histologic cell type and grade, the expression data of the 19 kinases in primary tumors described a greater degree of heterogeneity than is generally appreciated by clinicopathologic classification schemes. This diversity suggests that sarcomas, even those that appear to be clinically similar, arise through a variety of molecular pathways involving tyrosine kinases.
AbstractList BACKGROUNDThe tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas.METHODSTo characterize the protein tyrosine kinases that are expressed in human sarcomas, we used a polymerase chain reaction (PCR)-based method to construct kinase-specific cDNA libraries from low-grade and high-grade primary tumors. Thereafter, individual tyrosine kinase gene expression was assessed in a panel of sarcoma cell lines and primary tumors using Northern blotting and PCR.RESULTSWe identified 19 species of tyrosine kinase genes, including many growth factor receptors, the human homolog of the focal adhesion kinase (FAK) gene, and a novel trk-related kinase designated HGK2. Messenger RNA expression analyses showed relative overexpression of the two forms of the platelet-derived growth factor receptors (PDGFRs) with expression of the alpha form restricted to a subgroup of high-grad and metastatic sarcomas. We were unable to demonstrate coexpression of the PDGF isoforms in primary tumors that overexpressed the receptors, suggesting that a PDGF/PDGFR autocrine pathway may not be a central mechanism in the malignant transformation of sarcomas in vivo. FAK expression was observed in a variety of sarcomas, with increased levels in several high-grade and metastatic leiomyosarcomas.CONCLUSIONSWhen grouped together by histologic cell type and grade, the expression data of the 19 kinases in primary tumors described a greater degree of heterogeneity than is generally appreciated by clinicopathologic classification schemes. This diversity suggests that sarcomas, even those that appear to be clinically similar, arise through a variety of molecular pathways involving tyrosine kinases.
The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have not been systematically studied in the pathogenesis and progression of human sarcomas. To characterize the protein tyrosine kinases that are expressed in human sarcomas, we used a polymerase chain reaction (PCR)-based method to construct kinase-specific cDNA libraries from low-grade and high-grade primary tumors. Thereafter, individual tyrosine kinase gene expression was assessed in a panel of sarcoma cell lines and primary tumors using Northern blotting and PCR. We identified 19 species of tyrosine kinase genes, including many growth factor receptors, the human homolog of the focal adhesion kinase (FAK) gene, and a novel trk-related kinase designated HGK2. Messenger RNA expression analyses showed relative overexpression of the two forms of the platelet-derived growth factor receptors (PDGFRs) with expression of the alpha form restricted to a subgroup of high-grad and metastatic sarcomas. We were unable to demonstrate coexpression of the PDGF isoforms in primary tumors that overexpressed the receptors, suggesting that a PDGF/PDGFR autocrine pathway may not be a central mechanism in the malignant transformation of sarcomas in vivo. FAK expression was observed in a variety of sarcomas, with increased levels in several high-grade and metastatic leiomyosarcomas. When grouped together by histologic cell type and grade, the expression data of the 19 kinases in primary tumors described a greater degree of heterogeneity than is generally appreciated by clinicopathologic classification schemes. This diversity suggests that sarcomas, even those that appear to be clinically similar, arise through a variety of molecular pathways involving tyrosine kinases.
Author Weiner, T M
Craven, R J
Cance, W G
Liu, E T
Author_xml – sequence: 1
  givenname: T M
  surname: Weiner
  fullname: Weiner, T M
  organization: Department of Surgery, University of North Carolina School of Medicine, Chapel Hill
– sequence: 2
  givenname: E T
  surname: Liu
  fullname: Liu, E T
– sequence: 3
  givenname: R J
  surname: Craven
  fullname: Craven, R J
– sequence: 4
  givenname: W G
  surname: Cance
  fullname: Cance, W G
BackLink https://www.ncbi.nlm.nih.gov/pubmed/7834423$$D View this record in MEDLINE/PubMed
BookMark eNpFkDtPwzAUhS1UVNrCwo7kiQE14EdiJyNU5SFVYukeOck1CSR2sR3R_nsCjWC6RzqfjnS_OZoYawChS0puKSHy7uGRME54wuUJmtGEx1EsUjoZMhFplDGRnKG59--EUMlJMkVTmfI4ZnyG9uv9zoH3jTXYavzm7FeosVZlsA47KGE3BL_EoQasbalarKoafvGPxigPS6xMhe3QOxwOzvrGwFh53Bhc950y2FsdcGi87wGHvhsmz9GpVq2Hi_Eu0PZxvV09R5vXp5fV_SYqWcpCVEEm0zLTDFjBtUx1yiopMx6LqogLyjRonnHQQpS64DSllCsoqiSOhRCV4At0fZzdOfvZgw951_gS2lYZsL3PpZSMJoIO4M0RLIcfvAOd71zTKXfIKcl_LOf_lgf4alztiw6qP3TUyr8BVAd7Cw
CitedBy_id crossref_primary_10_1517_13543776_12_3_369
crossref_primary_10_1016_S0959_8049_98_00247_0
crossref_primary_10_1002__SICI_1098_2744_199905_25_1_73__AID_MC9_3_0_CO_2_U
crossref_primary_10_1016_j_exer_2003_10_002
crossref_primary_10_1158_0008_5472_CAN_03_0245
crossref_primary_10_1002_cncr_26334
crossref_primary_10_1016_j_bbrc_2003_10_060
crossref_primary_10_1007_BF02409059
crossref_primary_10_1007_s10549_004_1022_8
crossref_primary_10_1038_modpathol_3800424
crossref_primary_10_1016_j_bbagrm_2008_11_002
crossref_primary_10_1074_jbc_M414172200
crossref_primary_10_3390_ijms23084125
crossref_primary_10_1002_jcb_20046
crossref_primary_10_1016_j_bbaexp_2004_03_002
crossref_primary_10_1016_S0748_7983_03_00120_3
crossref_primary_10_1379_1466_1268_2001_006_0105_GTPOAC_2_0_CO_2
crossref_primary_10_1158_0008_5472_CAN_07_6268
crossref_primary_10_1007_s11864_003_0045_4
crossref_primary_10_5858_1999_123_1246_MPOSTA
crossref_primary_10_1016_S0960_7404_03_00004_5
crossref_primary_10_3390_cancers14061561
crossref_primary_10_1186_2053_6844_1_2
crossref_primary_10_1371_journal_pone_0115916
crossref_primary_10_1002_mc_20552
crossref_primary_10_1158_1078_0432_CCR_13_1594
crossref_primary_10_1016_S0167_4889_01_00123_9
crossref_primary_10_1016_j_lungcan_2006_06_001
crossref_primary_10_1074_jbc_M701450200
crossref_primary_10_1002__SICI_1097_0215_19960529_66_5_669__AID_IJC15_3_0_CO_2
crossref_primary_10_1002_ijc_2910600611
crossref_primary_10_1016_j_ejca_2007_10_012
crossref_primary_10_1016_j_ejcb_2020_151083
crossref_primary_10_1053_jhep_2003_50457
crossref_primary_10_1002_pros_10114
crossref_primary_10_1016_S0736_5748_00_00041_1
crossref_primary_10_4236_jct_2012_31002
crossref_primary_10_1007_BF01220799
crossref_primary_10_1042_BC20100094
crossref_primary_10_1007_BF02306088
crossref_primary_10_1016_j_jhep_2004_03_029
crossref_primary_10_1002_cncr_29858
crossref_primary_10_1074_jbc_M205002200
crossref_primary_10_1517_14728220903460340
crossref_primary_10_1529_biophysj_105_074526
crossref_primary_10_1074_jbc_273_27_17102
crossref_primary_10_1097_00129039_200412000_00009
crossref_primary_10_1007_s00280_004_0780_7
crossref_primary_10_1128_MCB_19_12_8075
crossref_primary_10_1002__SICI_1097_0142_19991015_86_6_1551__AID_CNCR23_3_0_CO_2_P
crossref_primary_10_1006_excr_1998_4327
crossref_primary_10_1007_BF00123398
Cites_doi 10.1002/ijc.2910390605
10.1128/MCB.12.4.1698
10.1172/JCI113137
10.1016/0092-8674(90)90659-3
10.1016/0960-7404(92)90092-Y
10.1093/nar/12.1Part1.387
10.1126/science.3798106
10.1126/science.3291115
10.1016/0092-8674(90)90801-K
10.1128/MCB.11.10.5016
10.1002/ijc.2910460620
10.1038/319743a0
10.1126/science.1312256
10.1038/358690a0
10.1073/pnas.89.11.5192
10.1016/0092-8674(91)90637-E
10.1016/0735-0651(89)90020-4
10.1038/313745a0
10.1126/science.6538699
10.1002/ijc.2910540409
10.1073/pnas.87.15.5863
10.1073/pnas.86.5.1603
10.1016/0092-8674(91)90639-G
10.1056/NEJM199011223232105
10.1073/pnas.74.12.5463
10.1073/pnas.88.19.8392
10.1016/0896-6273(91)90167-X
10.1126/science.1659742
10.1073/pnas.89.7.2960
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1007/BF02303537
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1534-4681
EndPage 27
ExternalDocumentID 10_1007_BF02303537
7834423
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA01625
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
199
1N0
1SB
203
23M
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2WC
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6J9
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAEOY
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACREN
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFJLC
AFKRA
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJOOF
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BAWUL
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
C1A
CAG
CCPQU
CGR
COF
CS3
CSCUP
CUY
CVF
DDRTE
DIK
DL5
DNIVK
DPUIP
E3Z
EBD
EBLON
EBS
ECM
EIF
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GX1
GXS
H13
HEOXT
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IH2
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
L7B
LAS
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPM
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
OWW
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOQ
YFH
YLTOR
Z45
Z7U
Z7X
Z82
Z83
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c282t-de978c9f2e2b3f78f82d779346db4b12fef393ef66cfb318113aebd544666d63
ISSN 1068-9265
IngestDate Fri Oct 25 23:12:37 EDT 2024
Fri Nov 22 00:56:55 EST 2024
Tue Oct 15 23:15:15 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c282t-de978c9f2e2b3f78f82d779346db4b12fef393ef66cfb318113aebd544666d63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 7834423
PQID 77721561
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_77721561
crossref_primary_10_1007_BF02303537
pubmed_primary_7834423
PublicationCentury 1900
PublicationDate 1994-Jan
1994-1-00
19940101
PublicationDateYYYYMMDD 1994-01-01
PublicationDate_xml – month: 01
  year: 1994
  text: 1994-Jan
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Annals of surgical oncology
PublicationTitleAlternate Ann Surg Oncol
PublicationYear 1994
References 2406025 - Cell. 1990 Feb 23;60(4):557-63
1341265 - Surg Oncol. 1992 Aug;1(4):309-14
2466296 - Proc Natl Acad Sci U S A. 1989 Mar;86(5):1603-7
2158859 - Cell. 1990 Apr 20;61(2):203-12
1933904 - Cancer Res. 1991 Dec 1;51(23 Pt 1):6393-6
3883191 - Nature. 1985 Feb 28-Mar 6;313(6005):745-7
1317261 - Cancer Res. 1992 Jun 1;52(11):3213-9
1656220 - Mol Cell Biol. 1991 Oct;11(10):5016-31
2169345 - Cancer Res. 1990 Oct 1;50(19):6344-8
2233918 - N Engl J Med. 1990 Nov 22;323(21):1457-62
1594631 - Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5192-6
1659742 - Science. 1991 Nov 22;254(5035):1146-53
2887586 - J Clin Invest. 1987 Sep;80(3):804-11
271968 - Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
1313574 - Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2960-4
2025425 - Neuron. 1991 May;6(5):691-704
1988147 - Cell. 1991 Jan 25;64(2):249-70
1312667 - Mol Cell Biol. 1992 Apr;12(4):1698-707
2869410 - Nature. 1986 Feb 27-Mar 5;319(6056):743-8
2536861 - Lab Invest. 1989 Feb;60(2):245-53
1309926 - Lab Invest. 1992 Jan;66(1):108-15
1379699 - Nature. 1992 Aug 20;358(6388):690-2
1653246 - J Biol Chem. 1991 Sep 5;266(25):16755-63
1320245 - Oncogene. 1992 Jul;7(7):1355-9
1717976 - Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8392-6
2569437 - Gene Anal Tech. 1989 Jul-Aug;6(4):79-83
6546423 - Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387-95
2143022 - Proc Natl Acad Sci U S A. 1990 Aug;87(15):5863-7
1656371 - Oncogene. 1991 Sep;6(9):1677-83
6538699 - Science. 1984 Apr 20;224(4646):256-62
1661131 - Cell Growth Differ. 1991 Oct;2(10):495-501
1312256 - Science. 1992 Feb 21;255(5047):989-91
8099900 - Int J Cancer. 1993 Jun 19;54(4):571-7
2841235 - Important Adv Oncol. 1987;:87-104
1314366 - Oncogene. 1992 Apr;7(4):627-33
3291115 - Science. 1988 Jul 1;241(4861):42-52
3473046 - Int J Cancer. 1987 Jun 15;39(6):685-8
3798106 - Science. 1987 Jan 9;235(4785):177-82
1655243 - Cancer Res. 1991 Oct 1;51(19):5087-92
1846320 - Cell. 1991 Jan 25;64(2):281-302
1372158 - Am J Pathol. 1992 Mar;140(3):639-48
2174413 - Int J Cancer. 1990 Dec 15;46(6):1066-70
M Grieco (BF02303537_CR7) 1990; 60
A Ullrich (BF02303537_CR10) 1990; 61
AF Wilks (BF02303537_CR14) 1989; 86
WG Cance (BF02303537_CR25) 1993; 54
B Westermark (BF02303537_CR35) 1991; 51
MB Sporn (BF02303537_CR13) 1985; 313
F Sanger (BF02303537_CR18) 1977; 74
MD Schaller (BF02303537_CR27) 1992; 89
P Leveen (BF02303537_CR28) 1990; 46
SK Hanks (BF02303537_CR8) 1988; 241
WG Cance (BF02303537_CR3) 1990; 323
WA Franklin (BF02303537_CR30) 1990; 50
SA Aaronson (BF02303537_CR11) 1991; 254
WG Cance (BF02303537_CR20) 1992; 1
TP Fleming (BF02303537_CR36) 1992; 7
T Hunter (BF02303537_CR9) 1991; 69
BI Terman (BF02303537_CR22) 1991; 6
PM Meltzer (BF02303537_CR5) 1991; 2
C Lai (BF02303537_CR15) 1991; 6
JP O'Bryan (BF02303537_CR24) 1991; 11
T Kumabe (BF02303537_CR33) 1992; 7
J Devereux (BF02303537_CR19) 1984; 12
CJ Thiele (BF02303537_CR43) 1987; 86
C DeVries (BF02303537_CR23) 1992; 55
J-L Guan (BF02303537_CR39) 1992; 358
MA Israel (BF02303537_CR42) 1987
LC Cantley (BF02303537_CR12) 1991; 64
J Partanen (BF02303537_CR26) 1992; 12
PM Perosio (BF02303537_CR31) 1989; 60
M Hermanson (BF02303537_CR34) 1992; 52
A Smits (BF02303537_CR37) 1992; 140
M Katoh (BF02303537_CR21) 1992; 89
D Martin-Zanca (BF02303537_CR40) 1986; 319
DJ Slamon (BF02303537_CR41) 1984; 224
LJ Kornberg (BF02303537_CR38) 1991; 88
N Mandahl (BF02303537_CR4) 1987; 39
DG Brachman (BF02303537_CR1) 1991; 51
R Jansen (BF02303537_CR17) 1989; 6
J Sambrook (BF02303537_CR16) 1989
C Palman (BF02303537_CR29) 1992; 66
DJ Slamon (BF02303537_CR6) 1987; 235
LM Mulligan (BF02303537_CR2) 1990; 87
M Nister (BF02303537_CR32) 1991; 266
References_xml – volume: 39
  start-page: 685
  year: 1987
  ident: BF02303537_CR4
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910390605
  contributor:
    fullname: N Mandahl
– volume: 50
  start-page: 6344
  year: 1990
  ident: BF02303537_CR30
  publication-title: Cancer Res
  contributor:
    fullname: WA Franklin
– volume: 12
  start-page: 1698
  year: 1992
  ident: BF02303537_CR26
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.12.4.1698
  contributor:
    fullname: J Partanen
– volume: 86
  start-page: 804
  year: 1987
  ident: BF02303537_CR43
  publication-title: J Clin Invest
  doi: 10.1172/JCI113137
  contributor:
    fullname: CJ Thiele
– volume: 60
  start-page: 557
  year: 1990
  ident: BF02303537_CR7
  publication-title: Cell
  doi: 10.1016/0092-8674(90)90659-3
  contributor:
    fullname: M Grieco
– volume: 1
  start-page: 309
  year: 1992
  ident: BF02303537_CR20
  publication-title: Surg Oncol
  doi: 10.1016/0960-7404(92)90092-Y
  contributor:
    fullname: WG Cance
– volume: 266
  start-page: 16755
  year: 1991
  ident: BF02303537_CR32
  publication-title: J Biochem
  contributor:
    fullname: M Nister
– volume: 60
  start-page: 245
  year: 1989
  ident: BF02303537_CR31
  publication-title: Lab Invest
  contributor:
    fullname: PM Perosio
– volume: 12
  start-page: 387
  year: 1984
  ident: BF02303537_CR19
  publication-title: Nucl Acid Res
  doi: 10.1093/nar/12.1Part1.387
  contributor:
    fullname: J Devereux
– volume: 7
  start-page: 1355
  year: 1992
  ident: BF02303537_CR36
  publication-title: Oncogene
  contributor:
    fullname: TP Fleming
– volume: 52
  start-page: 3213
  year: 1992
  ident: BF02303537_CR34
  publication-title: Cancer Res
  contributor:
    fullname: M Hermanson
– volume: 235
  start-page: 177
  year: 1987
  ident: BF02303537_CR6
  publication-title: Science
  doi: 10.1126/science.3798106
  contributor:
    fullname: DJ Slamon
– volume: 241
  start-page: 42
  year: 1988
  ident: BF02303537_CR8
  publication-title: Science
  doi: 10.1126/science.3291115
  contributor:
    fullname: SK Hanks
– volume: 61
  start-page: 203
  year: 1990
  ident: BF02303537_CR10
  publication-title: Cell
  doi: 10.1016/0092-8674(90)90801-K
  contributor:
    fullname: A Ullrich
– volume: 11
  start-page: 5016
  year: 1991
  ident: BF02303537_CR24
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.11.10.5016
  contributor:
    fullname: JP O'Bryan
– volume: 46
  start-page: 1066
  year: 1990
  ident: BF02303537_CR28
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910460620
  contributor:
    fullname: P Leveen
– volume: 319
  start-page: 743
  year: 1986
  ident: BF02303537_CR40
  publication-title: Nature
  doi: 10.1038/319743a0
  contributor:
    fullname: D Martin-Zanca
– volume: 55
  start-page: 989
  year: 1992
  ident: BF02303537_CR23
  publication-title: Science
  doi: 10.1126/science.1312256
  contributor:
    fullname: C DeVries
– volume: 140
  start-page: 639
  year: 1992
  ident: BF02303537_CR37
  publication-title: Am J Pathol
  contributor:
    fullname: A Smits
– volume: 358
  start-page: 690
  year: 1992
  ident: BF02303537_CR39
  publication-title: Nature
  doi: 10.1038/358690a0
  contributor:
    fullname: J-L Guan
– volume: 89
  start-page: 5192
  year: 1992
  ident: BF02303537_CR27
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.89.11.5192
  contributor:
    fullname: MD Schaller
– volume: 69
  start-page: 249
  year: 1991
  ident: BF02303537_CR9
  publication-title: Cell
  doi: 10.1016/0092-8674(91)90637-E
  contributor:
    fullname: T Hunter
– volume: 6
  start-page: 79
  year: 1989
  ident: BF02303537_CR17
  publication-title: Gene Anal Tech
  doi: 10.1016/0735-0651(89)90020-4
  contributor:
    fullname: R Jansen
– volume: 313
  start-page: 745
  year: 1985
  ident: BF02303537_CR13
  publication-title: Nature
  doi: 10.1038/313745a0
  contributor:
    fullname: MB Sporn
– volume: 66
  start-page: 108
  year: 1992
  ident: BF02303537_CR29
  publication-title: Lab Invest
  contributor:
    fullname: C Palman
– volume: 224
  start-page: 256
  year: 1984
  ident: BF02303537_CR41
  publication-title: Science
  doi: 10.1126/science.6538699
  contributor:
    fullname: DJ Slamon
– volume: 51
  start-page: 5087
  year: 1991
  ident: BF02303537_CR35
  publication-title: Cancer Res
  contributor:
    fullname: B Westermark
– volume: 54
  start-page: 571
  year: 1993
  ident: BF02303537_CR25
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910540409
  contributor:
    fullname: WG Cance
– volume: 87
  start-page: 5863
  year: 1990
  ident: BF02303537_CR2
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.87.15.5863
  contributor:
    fullname: LM Mulligan
– volume: 86
  start-page: 1603
  year: 1989
  ident: BF02303537_CR14
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.86.5.1603
  contributor:
    fullname: AF Wilks
– volume: 64
  start-page: 281
  year: 1991
  ident: BF02303537_CR12
  publication-title: Cell
  doi: 10.1016/0092-8674(91)90639-G
  contributor:
    fullname: LC Cantley
– start-page: 87
  volume-title: Important advances in oncology
  year: 1987
  ident: BF02303537_CR42
  contributor:
    fullname: MA Israel
– volume: 323
  start-page: 1457
  year: 1990
  ident: BF02303537_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199011223232105
  contributor:
    fullname: WG Cance
– volume: 2
  start-page: 495
  year: 1991
  ident: BF02303537_CR5
  publication-title: Cell Growth Diff
  contributor:
    fullname: PM Meltzer
– volume: 74
  start-page: 5463
  year: 1977
  ident: BF02303537_CR18
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.74.12.5463
  contributor:
    fullname: F Sanger
– volume: 6
  start-page: 1677
  year: 1991
  ident: BF02303537_CR22
  publication-title: Oncogene
  contributor:
    fullname: BI Terman
– volume: 88
  start-page: 8392
  year: 1991
  ident: BF02303537_CR38
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.88.19.8392
  contributor:
    fullname: LJ Kornberg
– volume: 6
  start-page: 691
  year: 1991
  ident: BF02303537_CR15
  publication-title: Neuron
  doi: 10.1016/0896-6273(91)90167-X
  contributor:
    fullname: C Lai
– volume: 7
  start-page: 627
  year: 1992
  ident: BF02303537_CR33
  publication-title: Oncogene
  contributor:
    fullname: T Kumabe
– volume: 51
  start-page: 6393
  year: 1991
  ident: BF02303537_CR1
  publication-title: Cancer Res
  contributor:
    fullname: DG Brachman
– volume: 254
  start-page: 1146
  year: 1991
  ident: BF02303537_CR11
  publication-title: Science
  doi: 10.1126/science.1659742
  contributor:
    fullname: SA Aaronson
– start-page: 7.39
  volume-title: Molecular cloning: a laboratory manual
  year: 1989
  ident: BF02303537_CR16
  contributor:
    fullname: J Sambrook
– volume: 89
  start-page: 2960
  year: 1992
  ident: BF02303537_CR21
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.89.7.2960
  contributor:
    fullname: M Katoh
SSID ssj0017305
Score 1.7366818
Snippet The tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers, but have...
BACKGROUNDThe tyrosine kinases are a family of genes that includes many growth factor receptors and protooncogenes. They appear to have a role in many cancers,...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 18
SubjectTerms Amino Acid Sequence
Blotting, Northern
Cell Adhesion Molecules - genetics
Cell Adhesion Molecules - metabolism
Focal Adhesion Kinase 1
Focal Adhesion Protein-Tyrosine Kinases
Humans
Molecular Sequence Data
Polymerase Chain Reaction
Protein-Tyrosine Kinases - genetics
Protein-Tyrosine Kinases - metabolism
Receptors, Platelet-Derived Growth Factor - metabolism
Sarcoma - genetics
Sarcoma - metabolism
Soft Tissue Neoplasms - genetics
Soft Tissue Neoplasms - metabolism
Title Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors
URI https://www.ncbi.nlm.nih.gov/pubmed/7834423
https://search.proquest.com/docview/77721561
Volume 1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9wwEBZNCqWX0lfoNo8K2tvGsLa0fhxD6pDSbXqoC7kZWY9mCbVDbEP67zPSyHaWpbQ99GKMjIWZ-fxpZjSaIeSDzHgFC7kIYG0zAa8kC0RmokCzVAnG-DIS9rzz-bfk4jL9mPN8iipNY_9V0zAGurYnZ_9B2-OkMAD3oHO4gtbh-ld6z-98aquzA3-Al91d-a46c2A3fWPb61jBWovTNK5WgLrS7oXrdS2w0aINp7uzWfPuF6yj1hTFhy59Fhv7tcDg884pbt71Pxu_L7RVmbntb5Fem1puBvH12h-3Kaag7GrdO35-kL1tOyRhqGDaxDq1aHUJgr47mPJH-fiDyAWS7SIGso2wV8TIxlugQ2b1LI1rNJYT2GL_xZDTDn4VW2Ixmc0S2xdfy7Pvq1VZ5JfFDnkcATs5P_zT53HrCShv6bbI_cdt1rT1M29aMb9xTZyJUjwnz7xvQU8QFC_II12_JE---OyJV-RuwgZtDEVsUMQGHbFxTEHv1CGDDsigqPxjCrigDhd0wIV_1NJ1TR0uqMUFRVxQxMVrUpzlxel54DtvBBJc8C5QOktSCf-sjipmktSkkUpAVjxWFa_CyGjDMqZNHEtTwaoQhkzoSi1tckCsYrZHduum1m8IlZXKdLLgYSZiHmemkrEJo4RLkUgBtvGMvB8EWd5gfZVyqKQ9iXtG3g0yLoH-7J6WqHXTt2UC3mEIPsCM7KHox1lcB5mIvf3jq_vk6YTOA7Lb3fb6kOy0qj9yyLgHMteDuA
link.rule.ids 315,782,786,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+of+growth+factor+receptors%2C+the+focal+adhesion+kinase%2C+and+other+tyrosine+kinases+in+human+soft+tissue+tumors&rft.jtitle=Annals+of+surgical+oncology&rft.au=Weiner%2C+T+M&rft.au=Liu%2C+E+T&rft.au=Craven%2C+R+J&rft.au=Cance%2C+W+G&rft.date=1994-01-01&rft.issn=1068-9265&rft.volume=1&rft.issue=1&rft.spage=18&rft.epage=27&rft_id=info:doi/10.1007%2FBF02303537&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1068-9265&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1068-9265&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1068-9265&client=summon